Copaxone Side Effects Long Term

Thus this multicenter retrospective cohort study aimed to assess the long term effectiveness of glatiramer acetate in this setting.

Copaxone side effects long term. The most common side effects of copaxone are redness pain swelling itching a lump or an indentation at the site of injection weakness infection pain nausea joint pain anxiety and. Copaxone starts working from the first injection. Serious side effects may happen right after or within. No severe long term side effect was observed although it has not been used at a large scale for a long time.

The study population included rrms patients treated with glatiramer acetate for at least 5years after its marketing authorization and the primary endpoint was long term clinical effectiveness defined as absence. Face edema is 3 for copaxone and 1 for placebo. Anxiety chest pain dyspnea lymphadenopathy palpitations post injection flare urticaria vasodilation flushing erythema at injection site induration at injection site. Some of the dosage forms listed on this page may not apply to the brand name copaxone.

Most people report it takes six to nine months before an effect is noticed. In some people it may take longer. Common side effects of copaxone include. This document contains side effect information about glatiramer.

However its effects may not be obvious for several months. These first generation dmds were seen as being expensive only modestly effective at reducing relapses and causing significant side effects. Copaxone is a prescription medicine that is used to treat relapsing forms of multiple sclerosis ms to include clinically isolated syndrome relapsing remitting disease and active secondary progressive disease in adults. Copaxone is considered a long term treatment for ms and it has been available for the treatment of ms for more than ten years.

But the copaxone prescribing information does have some information that might fit what you are looking for. The interferon beta betaferon betaseron rebif avonex and glatiramer acetate copaxone group of disease modifying drugs dmds have been given a bit of a tough time by many in the global ms community. 29 apr 2009 7 00 pdt new data presented provided evidence that long term treatment with copaxone glatiramer acetate injection may offer sustained protection from neuronal axonal injury. In the adverse effects from the clinical trials lymphadenopathy is listed as 7 for copaxone users and 3 for placebo users.

5 copaxone is advertised as the treatment which has the least side effects compared to interferons which could be a compensation for the everyday injection. Edema is 8 for copaxone and 2 for placebo. Php long term study with copaxone r indicated protective effect on brain tissue in multiple sclerosis patients article date. This is not a complete list of side effects and others may occur.

You may report side effects to fda at 1 800.